scholarly article | Q13442814 |
P2093 | author name string | Tanaka Y | |
Kinoshita M | |||
Hirai H | |||
Kimura S | |||
Muto Y | |||
Chiba S | |||
Ogawa S | |||
Honda H | |||
Mitani K | |||
Fukui T | |||
Kazuyama Y | |||
Kanda Y | |||
Osumi K | |||
Kami M | |||
Machida U | |||
P2860 | cites work | Real time quantitative PCR | Q29616373 |
The DNA sequence of the human cytomegalovirus genome | Q36465985 | ||
Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification | Q37126781 | ||
1994 Consensus Conference on Acute GVHD Grading | Q39513397 | ||
Detection of CMV DNA in bone marrow transplant recipients: plasma versus leucocyte polymerase chain reaction. | Q39563927 | ||
Rapid detection of cytomegalovirus in cell culture by indirect immunoperoxidase staining with monoclonal antibody to an early nuclear antigen | Q40221371 | ||
Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus | Q44658783 | ||
Cytomegalovirus DNA in the sera of patients with cytomegalovirus pneumonia | Q44894727 | ||
A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group | Q47573431 | ||
Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation | Q68262204 | ||
Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study | Q71775777 | ||
Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture | Q73536032 | ||
Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation | Q74015527 | ||
Time course analysis of semi-quantitative PCR and antigenaemia assay for prevention of cytomegalovirus disease after bone marrow transplantation | Q74122342 | ||
Lack of reactivity to CMV pp65 antigenemia testing in a patient with CMV disease following allogeneic bone marrow transplant | Q77227263 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | automation | Q184199 |
cytomegaloviral disease | Q2076966 | ||
Cytomegalovirus | Q6946 | ||
P304 | page(s) | 2536-2542 | |
P577 | publication date | 2000-07-01 | |
P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
P1476 | title | Real-time automated PCR for early diagnosis and monitoring of cytomegalovirus infection after bone marrow transplantation | |
P478 | volume | 38 |
Q39437967 | Absence of CMV viremia in high-grade glioma patients under low dosage glucocorticoid treatment |
Q38776409 | Absence of Cytomegalovirus in Glioblastoma and Other High-grade Gliomas by Real-time PCR, Immunohistochemistry, and In Situ Hybridization |
Q35638781 | Automated extraction and quantification of human cytomegalovirus DNA in whole blood by real-time PCR assay |
Q54349350 | Clinical usefulness of plasma quantitative polymerase chain reaction assay: diagnosis of cytomegalovirus infection in kidney transplant recipients. |
Q40050877 | Colonic cytomegalovirus detection by mucosal PCR and antiviral therapy in ulcerative colitis |
Q37284695 | Comparison of quantitative cytomegalovirus real-time PCR in whole blood and pp65 antigenemia assay: clinical utility of CMV real-time PCR in hematopoietic stem cell transplant recipients |
Q42850271 | Cytomegalovirus DNA quantification using an automated platform for nucleic acid extraction and real-time PCR assay setup |
Q36705553 | Cytomegalovirus Pneumonia in Patients with Rheumatic Diseases After Immunosuppressive Therapy: A Single Center Study in China |
Q44603440 | Cytomegalovirus viral load monitoring after allogeneic bone marrow transplantation in patients receiving antiviral prophylaxis |
Q35110913 | Cytomegalovirus, human herpesvirus-6, and human herpesvirus-7 in hematological patients |
Q36397608 | Detection and monitoring of virus infections by real-time PCR. |
Q43223365 | Detection of cytomegalovirus in whole blood using three different real-time PCR chemistries |
Q73936579 | Development and evaluation of a real-time quantitative PCR for the detection of human cytomegalovirus |
Q45869936 | Development and validation of a real-time PCR assay for the detection and quantitation of p53 recombinant adenovirus in clinical samples from patients treated with Ad5CMV-p53 (INGN 201) |
Q42718485 | Development of real-time PCR assays for the quantitative detection of Epstein-Barr virus and cytomegalovirus, comparison of TaqMan probes, and molecular beacons |
Q74387823 | Diagnosis of herpesvirus infections of the central nervous system |
Q47570861 | Identification of clinically relevant cytomegalovirus infections in patients with inflammatory bowel disease |
Q34437840 | Improved monitoring of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation by an ultrasensitive plasma DNA PCR assay |
Q44418473 | Influence of antithymocyte globulin dose on outcome in cytomegalovirus‐seropositive recipients of partially T cell‐depleted stem cell grafts from matched‐unrelated donors |
Q39732759 | Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients |
Q44214552 | Monitoring cytomegalovirus infection by antigenemia assay and two distinct plasma real-time PCR methods after hematopoietic stem cell transplantation |
Q34991529 | Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma |
Q43973082 | Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction |
Q46661280 | Monitoring of cytomegalovirus reactivation in bone marrow transplant recipients by real-time PCR. |
Q44115580 | Multiplex real-time NASBA for monitoring expression dynamics of human cytomegalovirus encoded IE1 and pp67 RNA. |
Q40043443 | PCR detection of human herpesviruses in colonic mucosa of individuals with inflammatory bowel disease: Comparison with individuals with immunocompetency and HIV infection. |
Q36452454 | Prediction of cytomegalovirus (CMV) plasma load from evaluation of CMV whole-blood load in samples from renal transplant recipients |
Q35558815 | Prevention of Cytomegalovirus Disease in Recipients of Allogeneic Stem Cell Transplants |
Q34486465 | Principles of molecular microbiology testing methods |
Q39466867 | Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation |
Q36933563 | Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients. |
Q39463508 | Quantification of human cytomegalovirus DNA by real-time PCR. |
Q33974273 | Quantification of human cytomegalovirus DNA in bone marrow transplant recipients by real-time PCR. |
Q44654550 | Quantitation of cytomegalovirus (hCMV) DNA and ?-actin DNA by duplex real-time fluorescence PCR in solid organ (liver) transplant recipients |
Q45737431 | Quantitative monitoring of circulating Epstein-Barr virus DNA for predicting the development of posttransplantation lymphoproliferative disease |
Q39467349 | Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds |
Q45372130 | Reactivations of cytomegalovirus, human herpes virus 6, and Epstein-Barr virus differ with respect to risk factors and clinical outcome after hematopoietic stem cell transplantation |
Q56762421 | Real-time Fluorescent PCR Techniques to Study Microbial–Host Interactions |
Q35922545 | Real-time PCR assay compared to nested PCR and antigenemia assays for detecting cytomegalovirus reactivation in adult T-cell leukemia-lymphoma patients |
Q43883386 | Real-time PCR assays based on distinct genomic regions for cytomegalovirus reactivation following hematopoietic stem cell transplantation |
Q27472851 | Real-time PCR in clinical microbiology: applications for routine laboratory testing |
Q24514920 | Real-time PCR in virology |
Q34193292 | Real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples from mothers with primary infection. |
Q81261927 | Reconstitution of HLA-A*2402-restricted cytomegalovirus-specific T-cells following stem cell transplantation |
Q33591729 | Surveillance of active human cytomegalovirus infection in hematopoietic stem cell transplantation (HLA sibling identical donor): search for optimal cutoff value by real-time PCR. |
Q92072726 | Targeting a highly repeated germline DNA sequence for improved real-time PCR-based detection of Ascaris infection in human stool |
Q93024986 | Usefulness of aqueous and vitreous humor analysis in infectious uveitis |
Q40762485 | Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection |